Pharma Reaserch Prod Co Ltd (214450) — Financial Flexibility Index

Latest as of December 2025: 0.22x

Pharma Reaserch Prod Co Ltd (214450) has a Financial Flexibility Index of 0.22x as of December 2025. Free cash flow of ₩69.31 Billion (operating CF ₩61.53 Billion minus capex ₩7.79 Billion) represents 0% of total liabilities (₩320.01 Billion). Check 214450 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Financial Flexibility Index

0.22x
Free Cash Flow / Total Liabilities

Free Cash Flow

₩69.31 Billion
Operating CF − Capex

Total Liabilities

₩320.01 Billion
KRW

Capital Expenditures

₩7.79 Billion
KRW

Pharma Reaserch Prod Co Ltd Financial Flexibility Index (2015–2025)

Historical Financial Flexibility Index trend for Pharma Reaserch Prod Co Ltd across 11 annual periods. See Pharma Reaserch Prod Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Pharma Reaserch Prod Co Ltd (2015–2025)

Year-by-year free cash flow to debt coverage for Pharma Reaserch Prod Co Ltd. For the full company profile including market capitalisation, see market cap of Pharma Reaserch Prod Co Ltd.

Year Flexibility Index Free Cash Flow (KRW) Operating CF Total Liabilities YoY Change
2025 0.68x ₩218.94 Billion ₩183.16 Billion ₩320.01 Billion ▲ +9.7%
2024 0.62x ₩178.60 Billion ₩139.88 Billion ₩286.26 Billion ▼ -41.6%
2023 1.07x ₩78.14 Billion ₩64.95 Billion ₩73.09 Billion ▲ +86.4%
2022 0.57x ₩77.16 Billion ₩59.40 Billion ₩134.55 Billion ▼ -18.5%
2021 0.70x ₩85.94 Billion ₩65.30 Billion ₩122.20 Billion ▼ -22.1%
2020 0.90x ₩67.18 Billion ₩32.39 Billion ₩74.41 Billion ▲ +90.4%
2019 0.47x ₩28.86 Billion ₩19.27 Billion ₩60.85 Billion ▼ -15.0%
2018 0.56x ₩33.80 Billion ₩5.20 Billion ₩60.56 Billion ▼ -64.9%
2017 1.59x ₩16.19 Billion ₩8.56 Billion ₩10.18 Billion ▲ +20.8%
2016 1.32x ₩10.12 Billion ₩8.16 Billion ₩7.69 Billion ▲ +0.2%
2015 1.31x ₩16.49 Billion ₩16.02 Billion ₩12.56 Billion —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities